Drug Approval | October 20, 2021
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Second interchangeable biosimilar product approved by agency
Second interchangeable biosimilar product approved by agency
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
It is the first presbyopia-correcting lens implant for cataract surgery
The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
Equity raise to finance growth and investments in the biological space
Subscribe To Our Newsletter & Stay Updated
